药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Ponatinib.
Glucosamine
Clorindione
The risk or severity of bleeding can be increased when Clorindione is combined with Ponatinib.
Glucosamine
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Ponatinib.
Glucosamine
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Ponatinib.
Glucosamine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Ponatinib.
Glucosamine
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Ponatinib.
Glucosamine
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Ponatinib.
Glucosamine
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Ponatinib.
Glucosamine
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Ponatinib.
Glucosamine
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Ponatinib.
Glucosamine
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Ponatinib.
Glucosamine
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Ponatinib.
Glucosamine
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Ponatinib.
Glucosamine
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Ponatinib.
Glucosamine
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Ponatinib.
Glucosamine
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Ponatinib.
Glucosamine
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Ponatinib.
Glucosamine
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Ponatinib.
Glucosamine
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Ponatinib.
Glucosamine
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Ponatinib.